The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

PHASE3RecruitingINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2028

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE

TAI

transarterial chemoinfusion with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)

Trial Locations (1)

RECRUITING

Cancer Center of Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER